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Abstract
Streptococcal pullulanases have been recently proposed as key components of the metabolic machinery involved in
bacterial adaptation to host niches. By sequence analysis of the Group B Streptococcus (GBS) genome we found a novel
putative surface exposed protein with pullulanase activity. We named such a protein SAP. The sap gene is highly conserved
among GBS strains and homologous genes, such as PulA and SpuA, have been described in other pathogenic streptococci.
The SAP protein contains two N-terminal carbohydrate-binding motifs, followed by a catalytic domain and a C-terminal
LPXTG cell wall-anchoring domain. In vitro analysis revealed that the recombinant form of SAP is able to degrade a-glucan
polysaccharides, such as pullulan, glycogen and starch. Moreover, NMR analysis showed that SAP acts as a type I
pullulanase. Studies performed on whole bacteria indicated that the presence of a-glucan polysaccharides in culture
medium up-regulated the expression of SAP on bacterial surface as confirmed by FACS analysis and confocal imaging.
Deletion of the sap gene resulted in a reduced capacity of bacteria to grow in medium containing pullulan or glycogen, but
not glucose or maltose, confirming the pivotal role of SAP in GBS metabolism of a-glucans. As reported for other
streptococcal pullulanases, we found specific anti-SAP antibodies in human sera from healthy volunteers. Investigation of
the functional role of anti-SAP antibodies revealed that incubation of GBS in the presence of sera from animals immunized
with SAP reduced the capacity of the bacterium to degrade pullulan. Of interest, anti-SAP sera, although to a lower extent,
also inhibited Group A Streptococcus pullulanase activity. These data open new perspectives on the possibility to use SAP
as a potential vaccine component inducing functional cross-reacting antibodies interfering with streptococcal infections.
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Introduction
The use of carbon sources is essential to the ability of bacteria to
colonize the host and potentially cause disease in humans. In
particular, highly polymerized a-glucan polysaccharides, such as
starch and glycogen, are most likely to be found in environmental
niches. Indeed, it is known that dietary-derived starches are very
abundant in the human colon [1,2,3], while glycogen is deposited
in large amount in the vaginal ephitelium during times of high
estrogen availability [4,5]. Recent reports using in vivo models of
colonization showed a correlation between the expression of
proteins involved in sugars metabolism and virulence. For
example, the malto-oligosaccharide/maltodextrin–binding com-
ponent of the Group A streptococcus malto-oligosaccharide ABC
transporter has been shown to be directly involved in virulence in
a mouse model of oropharynx infection [6]. More recently,
Shelburne et al. demonstrated that in human saliva the transcript
levels of several GAS carbohydrate utilization proteins other than
glucose are highly expressed [7]. In addition, a signature-tagged
mutagenesis study on S. pneumoniae (SPN) highlighted that a
number of a-glucan–active enzymes seems to be virulence factors
in a mouse model of lung infection [8].
Because of the complex structures of highly polymerized a-
glucans, bacteria require an appropriate combination of enzymes
for de-polymerization to oligo- and monosaccharides. Among
these enzymes are ascribed pullulanases. Pullulanases have a
glycosidic hydrolase activity towards a-glucan polysaccharides and
are considered key extracellular components in bacterial metab-
olism. GAS and Streptococcus pneumoniae (SPN) pullulanases, named
PulA and SpuA respectively, have been recently described [9,10].
They are anchored to the cell wall at their C termini by an
LPXTG motif and possess a modular structure harboring a
carbohydrate binding motif belonging to family 41 (CBM41) well
distinct from the catalytic domain (CD) [11]. CBMs are currently
classified into 47 families on the basis of amino acid sequence [12].
In particular, family 41 in the CBM classification was identified for
the first time in a pullulanase enzyme of the marine bacterium
Thermotoga maritime and it shares a high specificity for a-glucans. Of
interest, PulA has been described to have multifunctional activities
as the capability to hydrolyze pullulan, a linear polysaccharide of
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[9,13] and to act as a strepadhesin able to bind to thyroglobulin,
submaxillar mucin, fetuin, and asialofetuin [9]. PulA expression is
up-regulated by Mga and down-regulated by Rgg, both of which
are central transcriptional regulators of S. pyogenes gene expression
[13]. In addition, it has been recently reported that the
recombinant forms of PulA and SpuA CBMs showed high affinity
for glycogen-rich alveolar type II cells [10].
Group B streptococcus (GBS) is an extracellular mucosal pathogen
causing neonatal meningitis and invasive diseases in non-pregnant
adults. GBS colonizes the lower gastrointestinal and genital tracts
of healthy adults, as approximately 20–30% of healthy women are
colonized rectovaginally with GBS [14]. To date, the mechanisms
underlying the capacity of GBS to use carbon sources available at
site of colonization are largely undefined. By sequence analysis of
the GBS genomes, we discovered a novel surface exposed a-glucan
degrading-enzyme belonging to the streptococcal family of pull-
ulanase (SAP). Functional characterization of SAP revealed that
the protein is immunogenic in humans and that sera from SAP
immunized animals are able to reduce the capacity of SAP to
degrade a-glucans. Of particular interest, anti-SAP sera were also
impairing GAS pullulanase activity. These evidences may draw up
the basis for new strategies for preventing the use of environmen-
tally available complex carbohydrates by streptococci.
Results
Identification and genomic analysis of SAP
The increasing interest on streptococcal metabolism of complex
host-derived carbohydrates supported by recent studies on the
involvement of metabolic genes in Group A streptococcus (GAS)
infections [15], led us to investigate the presence in GBS of
surface-associated genes with putative a-glucan hydrolase activity.
In silico analysis of recently sequenced GBS genomes [16,17,18]
revealed the presence of a gene (3759 bp) encoding a protein of
1252 amino acid sharing a multimodular architecture comprising
a leader peptide (residues 1–41) containing a YSIRK-G/S-like
motif [19]. A tandem of putative carbohydrate binding motifs
(CBMs) and a glycoside hydrolase catalytic module were also
identified (Fig. 1A). On this basis, we named this new protein
Streptococcus agalactiae pullulanase (SAP). The sap gene is present in
all sequenced GBS strains and the protein is highly conserved,
with an amino acid identity ranges between 98 and 100%. SAP
repeated CBMs bore ,20% amino acid sequence identity to
family 41 CBM found in a secreted Termotoga maritime pullulanase.
CBM41 binds tightly to a-glucan polysaccharide comprising
primarily a-(1,4) glycosidic linkages [10]. Of interest, we found
that CBMs also shared ,66% and ,54% identity to CBMs
described in GAS (Spy1972, PulA) and Streptococcus pneumoniae
(SPN) (SP0268, SpuA) pullulanases respectively (Fig. 1B). Of
interest, the second CBM also contains a putative fibronectin-like
domain (Fig. 1B, aminoacids in italics). The anchoring domain of
SAP to the peptidoglycan is formed by the consensus LPKTG
sequence, followed by a hydrophobic transmembrane segment and
a charged C-terminal tail. Analysis of the SAP amino acid
sequence revealed the presence of an YNWGY motif, common to
pullulanases (Fig. 1 C, red box). As shown in Fig. 1C, the catalytic
domain is composed by four regions (aa 717 to 723, aa 781 to 789,
aa 812 to 817, and aa 897 to 903) conserved among streptococcal
pullulanase enzymes (Fig. 1C, green boxes). The putative catalytic
triad Asp802-Glu831-Asp919 was identified inside each of the
catalytic domains (Fig. 1C). Moreover, we identified a tryptophan
residue and a tyrosine residue, in regions III and IV respectively,
as found in other pullulanases [20].
The recombinant form of SAP shows a specific
pullulanase enzymatic activity
The sap gene from the COH1 strain, without the signal
sequence and the cell-wall anchoring region, was cloned into
pET21b(+) expression vector. As shown in Fig. 2A, two main
bands of 130 and 98 kDa were observed on SDS-PAGE gel,
suggesting that two forms of the protein were being produced in E.
coli. This is in agreement with previous data reported in the
literature [21,22] and our data (Bombaci et al., unpublished
observations) indicating the same protein pattern for recombinant
PulA. On the basis of N-terminal sequencing analysis of the low
MW form of SAP, which revealed the MKVQPNDYVF motif, we
predicted a second putative GTG translational start codon within
the COH1 sap ORF at position +1036 and a possible Shine-
Dalgarno region (59-AGGAGA-39) 4 bp upstream of this point.
The resulting translation product obtained from this start site yield
a smaller protein lacking both CBMs. A mixture of the high and
low molecular weight forms of SAP (H+L) was purified by affinity
chromatography. Moreover, by anionic exchange chromatogra-
phy, we were also able to separate SAP (L) from SAP (H+L). Both
SAP recombinant preparations were used to demonstrate that a
pullulanase enzymatic activity was associated to the protein.
The capacity of recombinant SAP to catalyze the degradation of
a-glucan polysaccharides was tested by 3,5-dinitrosalicylic (DNS)
acid assay (see Experimental procedures). As shown in Fig. 3A,
recombinant SAP was active on pullulan, glycogen type IX from
bovine liver, amylopectin and starch, in which glucose residues are
linked by both a-1-4 and a-1-6 glycosidic linkages. On the
contrary, SAP was unable to catabolize amylose, which is a linear
glucose polymer carrying exclusively a-1-4 glycosidic linkages. For
the specific cleavage of a-1-6 glycosidic linkages, we hypothesize
that SAP is likely to be a Type I pullulanase [23].
Of interest, comparison of SAP(H+L) versus SAP(L) prepara-
tions, showed that they were both active on pullulan, starch and
amylopectin, while only SAP(H+L) was able to degrade glycogen.
This finding suggests that the CBM contributes to the specific
interaction with glycogen, in agreement with previous reports
[8,10].
In addition, we compared the enzymatic activity of SAP versus
GAS pullulanase (PulA) using different carbohydrates as sub-
strates. As shown in Fig. 3B, no statistically differences were
observed among SAP(H+L) and PulA for the capacity to degrade
pullulan, glycogen, amylopectin and starch. These data postulate
that, although the overall sequence conservation is around 60% of
identity, pullulanase enzymatic activity well correlates between
SAP and PulA.
SAP is a Type I pullulanase that generates maltotriose
residues
In order to confirm the classification of SAP as a type I
pullulanase we evaluated the modifications of the structure of
pullulan after incubation with SAP by NMR spectroscopy. Fig. 4A
shows the proton NMR spectra of pullulan incubated in the
presence or absence of SAP(H+L). All the signals have been
assigned by using
1H-
1H 2D NMR scalar chemical shift
correlation spectroscopy, which gave results in agreement with
the assignments reported in the literature [24]. The NMR
chemical shift of selected signals, particularly looking at the
anomeric region (about from 5.8 to 4.5 ppm), has been used to
monitor the structural degradation of the polysaccharides. The
1H
NMR spectrum of pullulan after the addition of SAP(H+L)
(Fig. 4A) contains the C1 protons present in the starting material
and a new anomeric a-linked signal [H1a
(C Maltotriose] at 5.33 ppm,
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PLoS ONE | www.plosone.org 2 November 2008 | Volume 3 | Issue 11 | e3787Figure 1. Modular organization of the SAP protein from the COH1 strain. (A) In green the signal peptide sequence. In gray the two tandems
CBM41, in yellow the catalytic domain (glycoside hydrolase family 13) and in red the C-terminal LPKTG cell-wall anchoring motif. (B) Sequence
alignments of individual CBM41s from GBS COH1 (SAN_1346), 515 (SAL_1339), CJB111 (SAM_1238), A909 (SAK_1302), NEM (gbs_1288), H36B
(SAI_1308), 2603 V/R (SAG_1216) strains, GAS SF370 strain (Spy_1972) and SPN TIGR4 strain (SP_0268). The conserved residues present in the a-
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reducing end b-linked signal [H1b
(C Maltotriose] is not detectable due
to the overlapping with the major HDO peak. Since the peak
integral ratio between (H1a
(C) Maltotriose+H1b
(C) Maltotriose) and
H1a
1-4 (A+B) Maltotriose is 1:2, we can conclude that the SAP cleaves
a-(1,6) glycosidic linkages between the units A and C generating
maltotriose units [25,26].
Glycogen molecular size distribution before and after the
addition of SAP(H+L) was instead determined by size exclusion
chromatography. As reported in Fig. 4B, the intensity of glycogen
RI signal decreased after 20 min from the addition of SAP(H+L).
From these data we can conclude that SAP is also active on
glycogen as confirmed by DNS acid assay.
Alpha-glucans modulates SAP expression on bacterial
surface
We observed that when GBS was grown in THB medium, a
rich medium normally used to culture GBS in laboratory, SAP was
not expressed on bacterial surface (data not shown). Since bacterial
pullulanases are known to be regulated by specific carbon sources
[27], we hypothesize that the amount of glucose in THB medium
(2 g/L) may down-regulate SAP expression. Therefore, expression
analysis was performed by using a Complex Medium (CM) to
which different a-glucans were added. We investigated the
mechanisms of regulation of SAP expression by RT-PCR,
Immuno-Electron Microscopy (IEM), confocal microscopy, FACS
and Western blotting (WB). As expected, SAP messenger RNA
transcript was undetectable when GBS was grown in CM
supplemented with glucose (Fig. 5A). On the other hand, a band
corresponding to SAP appeared in RNA extracts from bacteria
grown in CM plus maltose, pullulan or glycogen. As shown in
Fig, 5A, a single band recognized by anti-SAP antibodies was
revealed by WB analysis in the mutanolysin-sensitive peptidogly-
can protein fraction of bacteria grown in the presence of a-
glucans. Control experiments indicated that a cytosolic protein
(SAG0274), predicted to be an alpha-glycerophosphate oxidase,
was present in bacterial extracts but not in culture supernatants,
excluding the presence of contaminants from bacteria debris (data
not shown). In addition, FACS analysis (Table 1), IEM and
confocal imaging (Fig. 5B) also confirmed that SAP expression on
GBS surface is a-glucans dependent. To confirm the specificity of
the assays used, we constructed in COH1 strain a sap deletion
mutant. As expected, the mutant strain was negative for SAP
expression as confirmed by RT-PCR (Fig. 5A), WB analysis
(Fig. 5A) and FACS analysis (Table 1).
A SAP deficient mutant strain shows an impaired
capacity to grow in pullulan and glycogen containing
complex medium
To investigate whether SAP enzymatic activity is essential for
bacterial replication in the presence of a-glucans, we compared
COH1 wild type strain versus COH1Dsap strain for the ability to
grow in CM supplemented with different carbohydrates. As
expected no growth differences were observed among these strains
when glucose or maltose, that are not pullulanase substrates, were
added to the CM (Fig. 6A and B). On the other hand, the presence
of pullulan or glycogen in CM while did not affect the capacity of
the sap mutant strain to replicate, increased the growth rate of the
wild type strain (Fig. 6C and D).
In order to confirm that the capacity of GBS to hydrolyze a-
glucans is associated to an a increased expression of SAP, we
compared a total protein extract derived from COH1 wild type and
COH1Dsap strains grown in the presence of different carbohy-
drates, for the ability to degrade pullulan. As shown in the Fig. 7,
pullulanase activity was only observed in the protein extracts of
COH1 wild type grown in the presence of sugars inducing SAP
Figure 2. Expression of SAP recombinant protein. (A) SDS-PAGE of the mixture of the high and low molecular weight forms of SAP (left lane) as
obtained after affinity chromatography and SAP(L) as obtained after anionic exchange chromatography (right lane). (B) Schematic representation of
the recombinant form of SAP. Due to the presence of an alternative translation site the protein is expressed in two forms: SAP(H), the full-length form
of the enzyme; SAP(L), the truncated form without the CBMs.
doi:10.1371/journal.pone.0003787.g002
glucan binding site are boxed in red. In italics is indicated the fibronectin type III repeat. (C) Sequence alignment of the putative pullulanase catalytic
domains between GBS COH1 strain (SAN_1346), GAS SF370 strain (Spy_1972) and SPN TIGR4 strain (SP_0268). The four conserved regions designated
CDI, CDII, CDIII and CDIV form the catalytic domain and are boxed in green. Indicated with an asterisk are the amino acids forming the putative
catalytic triad Asp802-Glu831-Asp919. The YNWGY sequence motif is marked with a red box.
doi:10.1371/journal.pone.0003787.g001
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that GBS utilize a-glucans as a carbon energy source and that
pullulanase is indispensable to this activity.
SAP is recognized by human sera
Recent reports revealed that both sera from patients with GAS
and SPN infections contained antibodies reactive with pullulanases
[28,29]. In order to assess whether human sera recognized
recombinant SAP, we tested 4 sera from normal healthy
volunteers. By quantitative ELISA we found that all sera tested
showed antibody titers against SAP(H+L) and that IgG concen-
trations were in a range of 54.8–116.7 mg/ml, with a geometric
mean concentration of 76.7631.9 mg/ml. Of interest, antibody
titers against SAP(L) were lower compared to SAP(H+L) (Fig. 8A).
The specificity of the assay was confirmed by competitive ELISA
using the purified recombinant SAP protein as an inhibiting
antigen (Fig. 8B). The addition of an unrelated recombinant GBS
surface protein did not inhibit antibody binding to the SAP protein
in this assay (Fig. 8B). These findings other than indicating the
specificity of the antibody response towards SAP, suggest that the
CBMs might be important for the immunogenicity of the protein.
Anti-SAP antibodies block SAP and PulA enzymatic
activity
In order to test whether the immunoglobulin-mediated response
towards SAP impaired bacterial metabolic activity versus a-
glucans, we tested by DNS acid assay the capacity of mouse and
rabbit anti-SAP sera to prevent GBS pullulanase activity. We
performed dose-dependent experiments incubating SAP-express-
ing bacteria with different sera dilutions in a range between 0.1–
2%. As shown in Fig. 9, we observed that a SAP mouse antiserum
was able to block in a dose dependent fashion the ability of GBS
COH1 strain to degrade pullulan up to 80% of the initial activity
(Fig. 9A). As expected, the addition in the assay of two unrelated
sera did not inhibit GBS SAP activity (Fig. 9A). Similar results
were obtained performing the experiments using glycogen as a
substrate (data not shown). Depletion of specific anti-SAP
antibodies by absorbing the anti-SAP serum to a CNBR resin
coated with recombinant SAP, resulted in no inhibition of GBS
capacity to catabolize pullulan (Fig. 9A). As a control, the
absorbed anti-SAP serum lost the capacity to recognize the
recombinant form of SAP in immunoblotting assay (data not
shown). These data clearly postulate that anti-SAP antibodies
mediate in vivo prevention of GBS pullunase activity. The attempt
to reduce SAP enzymatic activity by adding to bacteria human
sera containing anti-SAP antibodies (up to a concentration of
10%) or anti-SAP antibodies purified from human sera was
unsuccessful (data not shown). We hypothesize that the quantity
and quality of anti-SAP antibodies derived from adult healthy
volunteers that have been in contact with GBS, is not sufficient for
our in vitro assay. Unfortunately, no sera from convalescent patients
or with GBS invasive disease are at the moment available in our
laboratory.
Since SAP CBM appears to be a very immunogenic domain
(Fig. 8A) and that it is highly homologous among streptococcal
pullulanases, we decided to test whether anti-SAP specific sera
were able to reduce the capacity of GAS to catabolize pullulan.
For these experiments we used GAS SF370 strain, which in the
presence of pullulan expresses PulA, as demonstrated by both
Western Blotting and FACS analysis (data not shown). As shown
in Fig. 9B, we observed that a SAP antiserum was able to reduce
the activity of GAS to catabolize pullulan, up to 50% of the initial
activity. These data confirm our hypothesis that the activity of
anti-pullulanase antibodies may be cross-species.
Discussion
The increasing need of new vaccine-based preventive strategies
replacing the antibiotic prophylaxis used for eradicating GBS
colonization of the genital tract of pregnant women, has recently
led to identification of antigens conferring a broad protection in
mice [30]. The discovery of novel immunogenic virulence factors
has also opened new perspectives to tackle GBS-associated
infections [31,32]. In this context, we considered of importance
the understanding of GBS genes involved in adaptive metabolism
of the bacterium. Indeed, the mechanisms underlying the capacity
of GBS to use complex carbon sources available at site of
colonization are largely undefined. Several lines of evidence are
now indicating that degradation of complex host-derived carbo-
Figure 3. Recombinant SAP enzymatic activity determined by
DNS acid assay (A) Determination of the activity of SAP
recombinant forms on different a-glucan substrates. The
mixtures contained 1% (w/v) of each substrate dissolved in PBS. After
incubation of recombinant SAP and a-glucans at 37uC for 1 h, DNS
buffer was added and the release of reducing groups was determined
by reading the absorption at 575 nm. The same sample without the
enzyme was used to correct for non-enzymatic release of reducing
sugars. (B) Comparison between recombinant SAP(H+L) and recombi-
nant PulA for the capacity to degrade a-glucans. Experimental protocol
as in (A). The data are the mean of 3 independent experiments 6 SD.
The asterisk indicates a significant difference between values (p,0,01).
doi:10.1371/journal.pone.0003787.g003
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PLoS ONE | www.plosone.org 5 November 2008 | Volume 3 | Issue 11 | e3787Figure 4. Analysis of SAP(H+L) enzymatic activity on pullulan and glycogen. (A) NMR spectra indicate the generation of maltotriose units
after the addition of SAP(H+L) to the reaction mixture containing pullulan. Pullulan NMR spectra were recorded on the native polysaccharide (2SAP)
and after the addition of the recombinant enzyme (+SAP). NMR experiments were recorded at 25uC on Bruker Avance 600 MHz spectrometer and
using 5-mm probe (Bruker). For details see the Experimental Procedures section. (B) SEC-HPLC analysis indicates that SAP(H+L) is active on glycogen.
Two chromatograms were recorded at 214nm, one on the native glycogen polysaccharide (black line) and the other 1 h later the addition of
SAP(H+L) (blue line). A gel filtration analytical column with a fractionation range of Mw PEG/PEO 2610
3–3610
5 Da was used. For details see the
Experimental Procedures section.
doi:10.1371/journal.pone.0003787.g004
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the transcriptome of GAS in a mouse soft tissue infection model
developed by J. Musser’s group [15], identified a series of genes
highly expressed during adaptive metabolic responses triggered by
nutrient signals and hypoxic/acidic conditions in the host. Of
interest, among them were identified genes related to amino acid
and maltodextrin utilization such as PulA. Indeed, GAS
metabolism of complex host-derived carbohydrates may be
particularly important during soft tissue infections because of
abundant host glycoproteins and host cell contents released during
cell lysis. GAS allows transcription of carbohydrate utilization
genes and virulence factors also in other low-glucose environmen-
tal conditions such as those found in human oropharynx and saliva
[15]. In agreement with our findings, it has been recently
demonstrated that GAS pullulanase is up regulated in bacteria
grown in human saliva, where glucose levels are low, compared to
the growth in nutrient rich medium [7]. On this basis, we
hypothesize that similar expression patterns may be induced by
GBS during colonization of lower gastro-intestinal and female
genital tracts, known to be poor in glucose but rich in a-glucans
[2,4]. Our data indicate that SAP-expressing GBS strains actively
degrade glycogen and that the recombinant form of SAP lacking
both CBMs loses activity versus this substrate. Based on these
evidence, we propose that SAP may have a role in vivo during the
establishment of vaginal colonization and confirms the specificity
of CBMs for glycogen [10]. Moreover, in silico analysis of GBS
available genomes revealed that SAP is the only surface associated
protein containing glycosidic domains (Santi et al., unpublished
results) and since SAP appears to be the only enzyme expressed by
GBS capable to catabolize a-glucans, we suggest that this enzyme
may be vital for GBS permanence in environmental niches poor in
glucose. We are currently testing this hypothesis, and preliminary
data have shown that deletion of the sap gene reduces the capacity
of GBS to colonize the vagina in a mouse model of infection
(Pezzicoli et al., unpublished results).
The importance of a-glucans metabolizing enzymes in strepto-
coccal adaptation to the host is further highlighted by recent
reports revealing they are immunogenic. Indeed, 81% of
convalescent-phase sera from patients with invasive GAS infec-
tions had antibodies reactive with PulA [28] and sera taken from
patient recovering from pneumococcal infections had high titers
against SpuA [29]. In agreement to this, we found that also SAP is
immunogenic in human sera, supporting the hypothesis that this
enzyme is expressed in vivo during GBS infections. However, to our
knowledge the functionality of streptococcal pullulanase-induced
antibody-mediated immune response has not been yet addressed.
The fact that incubation of bacteria with an anti-SAP serum
reduces GBS pullulanase activity, led us to hypothesize that in vivo
antibody-mediated immune response towards SAP might affect
GBS adaptive metabolism resulting in a decreased capacity to
survive in the host.
Emerging theories on human-microbe mutualism suggest that
the mechanisms that underlie microbial community structure and
host–symbiont relationships should be considered for planning
prevention strategies for human health. Indeed, as recently
proposed by David A. Relman [33], it should be investigated
the role of microbial communities, and not just individual species,
Figure 5. In vivo SAP protein expression is modulated by the presence of a-glucans. (A) RT-PCR and WB analysis of SAP expression in
COH1 wt strain and COH1Dsap strain grown in the presence of different sugars. Peptidoglycan-associated protein fraction was separated by 10% (w/
v) SDS-PAGE. Blots were overlaid with a mouse anti-SAP polyclonal antibody and stained with HRP-conjugated antibody. (B) Immunogold electron
microscopy and confocal imaging of SAP expression in COH1 wild type strain and COH1Dsap strain grown as in (A). For IEM, fixed bacteria were
incubated with an anti-SAP serum and then labeled with secondary antibody conjugated to 10-nm gold particles. Scale bars 200 nm. In confocal
imaging experiments, bacteria were stained with mouse polyclonal anti-capsular type III antibodies (red) and the SAP protein with rabbit polyclonal
anti-SAP antibodies (green). Magnification, 6100.
doi:10.1371/journal.pone.0003787.g005
Table 1. Exposure of SAP on bacterial surface in the presence
of different carbohydrates.
Glucose Maltose Pullulan Glycogen
COH1 7* 56 232 255
COH1Dsap 0 000
COH1-13 62 308 453 452
*Numbers indicate the delta mean of fluorescence relative to bacteria incubated
with a SAP immune serum versus bacteria incubated with a pre-immune
serum.
doi:10.1371/journal.pone.0003787.t001
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PLoS ONE | www.plosone.org 7 November 2008 | Volume 3 | Issue 11 | e3787Figure 6. The capacity of GBS to grown in pullulan and glycogen depends on SAP expression. The graphs represent the growth curves
relative to GBS COH1 wild type strain and COH1Dsap mutant strain grown in complex medium alone or with the addition of glucose (A), maltose (B),
pullulan (C) and glycogen (D). White circles indicate the COH1 wild type strain incubated in the presence of sugars, while white squares the same
strain incubated in complex medium alone. Black circles represent the COH1Dsap strain grown in complex medium supplemented with sugars, while
black squares are relative to the same strain grown in complex medium alone. A typical experiment, out of 4 performed giving identical results, is
shown. (E–F) Comparison of CFU/ml recovered after growing GBS COH1 wild type and COH1Dsap for 3 h in the presence of pullulan (E) or glycogen
(F). The data are the mean of 3 independent experiments 6 SD. The asterisk indicates a significant difference between values (p,0,01).
doi:10.1371/journal.pone.0003787.g006
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pathogens by affecting their metabolic activity towards essential
nutrients may be more effective than a general bactericidal
activity, as the one offered by an antibiotic treatment. Vaccines
able to specifically prevent infection from multiple microorganisms
are highly desirable. In this context, our finding that anti-SAP sera
other than preventing GBS catabolism of pullulan, significantly
reduce pullulanase activity in a GAS strain expressing PulA is of
extreme importance. In particular, we hypothesize that the
immunization of individuals with SAP will raise antibodies, which
by impairing the metabolic activity of pathogenic streptococci
might shift the equilibrium that regulates the colonized human
niches in favor of the commensal population.
In conclusion, the evidence reported in this paper may draw up the
basis for preventing streptococcal infections by using immunogenic
metabolic enzymes as target molecules for vaccine development. The
fact that, at least for pathogenic streptococci, such enzymes are well
conserved opens new perspectives in the development of strategies
preventing infections from multiple species.
Materials and Methods
Sequence analysis
The alignment of SAP protein encoded by sap gene from 2603 V/
R (TIGR Accession SAG_1216), 515 Ia (SAL_1339), NEM316
(gbs1288), H36B (SAI_1308), CJB111 (SAM_1238), A909
(SAK_1302) and COH1 (SAN_1346) strain as well as SpuA
(SP_0268) and PulA (Spy_1972) was performed using ClustalW [34].
Bacterial strains and growth conditions
S. agalactiae strains COH1 serotype III was used in this study.
Escherichia coli DH5a and DH10BT1 were used for cloning
purposes and E. coli BL21 (lDE3) for expression of SAP fusion
protein. S. agalactiae was cultivated at 37uC in Todd-Hewitt broth
(THB) up to desired OD600. E. coli was grown in Luria-Bertani
broth (LB); E. coli clones carrying the plasmids pJRS233 or
pET21(b)+ and derivates were grown in the presence erythromy-
cin (400 mg/mL) or ampicillin (100 mg/mL), respectively. The
complex medium (CM, 10 g/l proteose peptone, 5 g/l trypticase
peptone, 5 g/l yeast extract, 2.5 g/l KCl, 1mM Urea, 1mM
Arginine, pH 7.0) was used for GBS growth with defined carbon
sources. The sugar concentrations were 1% final. To evaluate
growth in CM, GBS was initially grown to log phase (OD600 0.3)
in THB. The cells were harvested by centrifugation, washed twice
in an equivalent volume of phosphate-buffered saline (PBS) and
diluted 1 to 50 in CM. Growth was monitored spectrophotomet-
rically at a wavelength of 600 nm.
SAP recombinant protein expression and purification
In order to express the recombinant form of SAP, the open
reading frame of the sap gene from S. agalactiae COH1 serotype III
was used as a template. The construct was amplified by PCR using
specific primers GBS5F and GBS5R introducing NdeI and XhoI
restriction enzyme sites (Table 2).
The PCR products were cloned into the pET21(b)+ vector and
the plasmid transformed in E. coli BL21 (DE3) cells. BL21 (DE3)
cells were grown in LB-Amp (100 mg/ml ampicillin) and induced
with IPTG at a final concentration of 1 mM for 3 hours. The
resulting biomass was suspended in 0.3 M NaCl, 50 mM Na-PO4
buffer, pH 8.0 and cells were lysed by enzymatic digestion. The
sample was then loaded onto a His-Trap Ni-Activated Chelating
Sepharose FF column (Amersham Biosciences, Milan, Italy) at a
flow rate of 5 ml/min. Bound proteins were then eluted from the
column by running a gradient from 0 to 50% of 500 mM
Imidazole, 0.3 M NaCl, 50 mM Na phosphate buffer, pH 8.0 in
12 CV. The IMAC eluted material was collected in 2.5-ml
fractions and those ones containing the SAP-His protein pooled.
An anionic exchange chromatography was used to separate the
two forms of SAP. The pooled fractions from Ni-IMAC were
dialyzed against 30mM TRIS, pH 8.0 and then loaded on to a
HiTrap Q HP 5 ml column (GE) to further purify the two forms of
recombinant SAP. The purification was achieved by running a
gradient from 0 to 50% 1M NaCl in 30mM TRIS, pH 8.0 in 16
CV at 5 ml/min. The collected fractions were analyzed by SDS-
PAGE (Criterion
TM pre-cast gel, 200V, 55 min) and pooled
according to apparent MW. The final preparation of the protein
was obtained in PBS, pH 7.4 after dialysis.
Construction of COH1 sap deletion mutant
The sap gene was deleted in GBS strain COH1, according to the
procedure previously described [35]. The in-frame deletion
fragment was obtained by Splicing Overlap Extension (SOE)
PCR using the primers P1, P2, P3 and P4 (Table 2). The XhoI
restriction enzyme cleavage sites were incorporated at the 59-end
of the primer to clone the fragment into the XhoI-digested
pJRS233 plasmid. After cloning the in frame deletion fragment in
pJRS233, the plasmid pJRS233Dsap was obtained.
The plasmid pJRS233Dsap was then transformed into the
COH1 strain by electroporation and transformants were selected
after growth at 30uC on agar plates containing 1 mg/ml
erythromycin. Transformants were then grown at 37uC with
erythromycin selection as previously described [36]. Integrant
strains were serially passaged for 5 days in liquid medium at 30uC
without erythromycin selection to facilitate the excision of plasmid
pJRS233Dsap, resulting in the sap deletion on the chromosome.
Dilutions of the serially passaged cultures were plated onto agar
plates, and single colonies were tested for erythromycin sensitivity
to confirm the excision of pJRS233Dsap. The resulting strain was
named COH1Dsap.
Bacterial extracts
GBS protein extracts were prepared by growing bacteria up to
OD600 0.4 in CM plus sugars, washed in PBS and incubated for
Figure 7. Detection of pullulanase activity in GBS total extracts.
Bacteria grown in a complex medium supplemented with the indicated
sugars were used to prepare total extracts. Bacterial extracts were then
incubated with pullulan and pullulanase enzymatic activity measured
by DNS acid assay. The asterisks indicate a significant difference
between the activity of the wild type strain versus the mutant strain
derived extracts (p,0,01). The data are the mean of 3 independent
experiments 6 SD.
doi:10.1371/journal.pone.0003787.g007
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protease inhibitors and 400 U/ml of mutanolysin (SIGMA, MO,
USA). The bacterial suspension was then pelleted and the
supernatants containing peptidoglycan associated proteins used
for western blotting analysis of SAP. In order to prepare GBS
extracts relative to the secreted protein fraction, supernatant of
bacteria cultures grown to OD600 0.4 were collected. Proteins in
1 ml of supernatant were precipitated with 10% of trichloroace-
ticacid (TCA) for 1 hr at 4uC. Protein were then pelletted, washed
with cold acetone and resuspended in Tris-HCl pH 6,8.
RT-PCR
COH1 was grown in CM medium plus sugars up to OD600 0.4.
Total GBS RNA was isolated using the Rneasy mini kit (Qiagen)
according to manufacturer’s instructions, except that bacteria were
lysed with 100 ml of lysozyme (30 mg/ml) in Tris-EDTA buffer
and 2,000 U of mutanolysin, and the mixture was incubated for
15 min at 37uC. Quantification of the transcripts was completed
by reverse transcription and semi-quantitative RT-PCR using
ImPromII RT (Promega) following manufacturer’s instructions.
Briefly 2 mg of sample and 0.5 mg of random hexamers were
added to a final volume of 5 ml. Samples were incubated in a
thermocycler (Biometra) at 70uC for 5 min followed by a quick
chill at 4uC. The mixture was used in a 20-ml (total volume) cDNA
synthesis reaction mixture comprising 4 ml of Improm-II 56
reaction buffer (Promega), 2.4 ml MgCl2 at 25 mM, 2 ml of dNTP
mix (each dNTP at 2.5 mM), 0.25 ml of Rnasin RNase inhibitor
(Promega) and 1 ml of Improm-II reverse transcriptase. The
reaction was performed at 42uC for 60 min. In the negative
controls, the reverse transcriptase was substituted with water. 2 ml
of cDNA were then added to the PCR reaction consisting of 16
reaction buffer, 200 mM dNTP’s, 0.2 mM primer pair, 1 U
PlatinumTaq dna polymerase (Invitrogen). GBS Gyrase A (GyrA)
was used as an internal housekeeping control. PCR reactions
consisted of a 7-min denaturation step 94uC, followed by a
variable number of cycles. PCR products were electrophoresed
through 2% agarose gels and images were acquired by laser
densitometry (Gel-Doc Imaging System).
Figure 8. Human sera specifically recognize SAP. (A) Immuno-reactivity of human sera towards recombinant SAP(H+L) and SAP(L). The data
were obtained by ELISA and represent the mean6SD of 4 human sera. (B) Results of competitive-inhibition ELISA demonstrating antigenic specificity
of human antibodies reacting with plates coated with recombinant SAP. Percent inhibition of binding of human serum by each inhibiting antigen
was determined by comparison of absorbance at 492 nm in the presence and absence of inhibitor. White circle labels indicate the mean6SD of the %
inhibition by SAP of 4 human sera. Black square labels indicate % inhibition by an unrelated GBS protein (AP-1).
doi:10.1371/journal.pone.0003787.g008
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Samples of pullulan (Sigma) and glycogen (Sigma) were
prepared by dissolving polysaccaride powder (10 mg) in 0.7 mL
of deuterated PBS buffer at pH 7.2 (D2O, 99.9% atom D –
Aldrich was used) to a uniform concentration. Samples were
therefore transferred to 5-mm NMR tubes (Wilmad Glass. Co.).
70 mL of SAP were therefore added to the pullulan and glycogen
samples in the NMR tubes. For every sample, two NMR spectra
were recorded, the first on the native polysaccharide and the
second 1 hour later (incubation at 25uC) after the addition of
enzyme. Samples of maltose (Sigma) and maltotriose were also
prepared by dissolving 10 mg of powder in 0.7 mL of deuterated
PBS buffer at pH 7.2.
1H NMR experiments were recorded at
25uC on Bruker Avance 600 MHz spectrometer and using 5-mm
probe (Bruker). For data acquisition and processing XWINNMR
software package (Bruker) was used. 1-D proton NMR spectra
were recorded using a standard one-pulse experiment. 64 scans
were collected and averaged, giving a total acquisition time of ca.
10 min. The transmitter was set at the HDO frequency, collecting
32 k data points over a spectral window of 6,000 Hz.
1H NMR
spectra were obtained in quantitative matter using a total recycle
time to ensure a full recovery of each signal (56 Longitudinal
Relaxation Time T1). Spectra were Fourier Transformed to 32 k
data points after applying a 0.2 Hz line broadening function and
referenced relative to the HDO resonance at 4.79 ppm.
Size Exclusion Chromatography (SEC)-HPLC analysis
Samples of glycogen were prepared by dissolving polysaccaride
powder (1 mg) in 0.1 mL of PBS at pH 7.2 to a uniform
concentration. Samples were therefore transferred to 1 mL vials
(Waters). 10 mL of SAP were therefore added to the glycogen
sample. Two chromatograms were recorded, the first on the native
polysaccharide and the second 1 hour later (incubation at 25uC)
after the addition of enzyme.
A TSK G4000PW (TosoHaas) gel filtration analytical column
(7.5 mm630.0 cm) with a fractionation range of Mw PEG/PEO
2,000–3610
5 Da was used. Samples were loaded onto the gel
filtration column and eluted isocratically in 100 mM sodium
phosphate + 100 mM NaCl buffer pH 7.2 at a flow rate of 0.5 ml
min
21 for 50 min. The elution was monitored with a Ultimate
3000 Photodiode Array detector (Dionex) coupled with the
Ultimate 3000 HPLC system (Dionex). For data acquisition and
processing Chromeleon software package (Dionex) was used.
Fluorescence-activated cell sorter analysis
In order to quantify the exposure of SAP on the bacterial
surface, GBS was grown up to OD600 0.4 in CM with 1% sugar,
fixed with 1% PFA for 20 min at RT and incubated with mouse
anti-SAP serum or mouse anti-PBS serum (negative control) in
0.1% BSA plus 20% of Normal Calf Serum (NCS) for 1 h at 4uC.
Bacteria were then washed in PBS containing 0.1% BSA and
incubated with the phicoerytrin (PE) conjugated secondary
antibodies (Jackson Immuno Research Inc., PA, USA) for
45 min at 4uC. After washing bacteria were resuspended in
Figure 9. Anti-SAP antibodies block SAP and PulA enzymatic
activity. (A) COH1 strain was grown in pullulan and assayed for the
capacity to degrade pullulan in the presence of different anti-sera. The
effect of specific anti-sera was tested in a dose range between 0.5 and
2%. White circles indicate the effect of a mouse anti-PBS serum; black
circles indicate the effect of an antiserum from an unrelated surface-
associated protein; black squares indicate the effect of a mouse anti-
SAP serum; white triangles indicate the effect of a mouse anti-SAP
serum absorbed to a CNBR resin coated with SAP. (B) as in (A) except for
testing the inhibitory activity of an anti-SAP serum on GAS SF370 strain.
doi:10.1371/journal.pone.0003787.g009
Table 2. List of primers used in the study.
Primer Sequence (59 to 39)
Recombinant protein
GBS5F CTAGCTAGCGAAGAAGTAAGTGTTTCTC
GBS5R CCCGCTCGAGATTAGCTTCATTTGTCAGA
COH1Dsap
P1 CCCGCTCGAGTCATCTACACACGCATTTTTCC
P2 TCCAGTTTTTGGCAAGGGAGTATTTTGCAATGTAGATGG
P3 TTGCAAAATACTCCCTTGCCAAAAACTGGAGATAAGTCA
P4 CCCGCTCGAGTTCCTAATGCTGTCTTCCCAAC
F corresponds to forward primer and R to reverse primer. Restriction sites are
underlined.
doi:10.1371/journal.pone.0003787.t002
GBS Pullulanase Activity
PLoS ONE | www.plosone.org 11 November 2008 | Volume 3 | Issue 11 | e3787200 ml of PBS and analyzed by a FACSscan flow cytometer
(Becton Dickinson) by using FlowJo software program.
Immunogold labeling and electron microscopy
GBS strains COH1 were grown at 37uCu pt oO D 600 0.3
(exponential phase) in CM plus 1% sugars. Bacteria were then
centrifuged for 10 min at 3000 rpm (RT), washed and resus-
pended in 1 ml of PBS. Formvar-carbon-coated nickel grids were
floated on drops of GBS suspensions for 5 min. The grids were
then fixed in 2% PFA for 5 min, and placed in blocking solution
(PBS containing 1% normal rabbit serum and 1% BSA) for
30 min. The grids were then floated on drops of primary
antiserum against the SAP protein diluted 1:20 in blocking
solution for 30 min at RT, washed with six drops of blocking
solution, and floated on secondary antibody conjugated to 10-nm
gold particles diluted 1:20 in 1% BSA for 30 min. The grids were
examined using a TEM GEOL 1200EX II transmission electron
microscope.
Confocal immunofluorescence microscopy
In order to visualize SAP on bacterial surface, COH1 was
grown in CM plus sugars up to OD600 0.4 and washed in PBS.
Bacterial pellet were fixed in 2% PFA for 20 min at RT and
spotted on POLYSINE
TM slides (Menzel-Glaser). The slides were
then blocked with 3% BSA for 1 h and incubated with a mix of
rabbit anti-serotype III capsule and mouse anti-SAP antibodies
diluted in 1% BSA for 1 h at RT. Bacteria were then stained with
goat anti-mouse and anti-rabbit Alexa Fluor conjugated antibodies
(excitation at 488 nm and 568 nm, respectively) (Molecular
Probes) for 20 min at RT. Slow Fade reagent kit (Molecular
Probes) was then used to mount cover slips. The slides were
analysed with a Bio-Rad confocal scanning microscope.
3,5-dinitrosalicylic acid (DNS) assay
Pullulanase activity was determined by measuring the enzymat-
ic release of reducing groups from a-glucans by the DNS
colorimetric method [37]. The mixtures contained 1% (w/v)
pullulan, glycogen type IX, amylose, amylopectin or soluble starch
(Sigma) dissolved in PBS (pH 7.0), and appropriately diluted
enzyme in a total volume of 500 mL. After incubation at 37uC for
1 h, the reaction was stopped by addition of 1 mL of cold DNS
buffer, followed by boiling for 15 min. 330 mL of a 40% potassium
sodium tartrate (Rochelle salt) solution was added to each tubes to
stabilize the color. The release of reducing groups from a-glucans
was determined by reading the absorption at 575 nm of the
sample. The same sample without the enzyme was used to correct
for non-enzymatic release of reducing sugars.
Serum-mediated inhibition of GBS and GAS pullulanase
activity
GBS and GAS were grown at 37uC up to mid-late exponential
phase (OD600 0.6) in THB and THY, respectively. Bacteria were
then re-inoculated in CM containing 1% pullulan and grown to
log phase (OD600 0.4) to allow the expression of pullulanases on
bacterial surface. The cells were then harvested by centrifugation,
washed twice with PBS and resuspended in PBS. Bacteria
(,5610
8 CFU) were pre-incubated with sera dilutions at 37uC
for 15 min, then pullulan was added (1% final) and the incubation
prolonged for other 2 hours. Samples were centrifuged and
supernatants were used for the determination of reducing sugars
by DNS acid assay.
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